Triasima Portfolio Management »

Royalty Pharma shares owned by Triasima Portfolio Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Triasima Portfolio Management from 13F filings

Historical chart of Triasima Portfolio Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Triasima Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Triasima Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 181k 56.07

More positions owned by Triasima Portfolio Management

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Millicom Intl Cellular S A Com Stk (TIGO)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Fortis (FTS)
HudBay Minerals (HBM)
Canadian Natl Ry (CNI)
Eli Lilly & Co. (LLY)
Celestica (CLS)
TJX Companies (TJX)
Bk Nova Cad (BNS)
Welltower Inc Com reit (WELL)

View all positions for Triasima Portfolio Management

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
State Street Corporation
Swedbank AB
Baillie Gifford & Co
Geode Capital Management
Capital World Investors
Caledonia
Norges Bank Investment Management
Vanguard Capital Management
Northern Trust
Royal London Asset Management
AQR Capital Management

View all funds holding Royalty Pharma